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Lymphoid tissue inducer cells are members of an
emerging family of innate lymphoid cells (ILC).
Although these cells were originally reported to
produce cytokines such as interleukin-17 (IL-17)
and IL-22, we demonstrate here that human
CD127+RORC+ and CD56+CD127+ LTi-like ILC also
express IL-2, IL-5, and IL-13after activationwithphys-
iologic stimuli such as common g-chain cytokines,
Toll-like receptor (TLR) 2 ligands, or IL-23. Whereas
TLR2 signaling induced IL-5, IL-13, and IL-22 expres-
sion in a nuclear factor kB (NF-kB)-dependent
manner, IL-23 costimulation induced only IL-22
production. CD127+ LTi-like ILC displayed clonal
heterogeneity for IL-13 and IL-5 production, suggest-
ing in vivo polarization. Finally, we identified a role for
autocrine IL-2 signaling in mediating the effects of
TLR2 stimulation on CD56+CD127+ and CD127+ LTi-
like ILC. These results indicate that human LTi-like
ILC can directly sense bacterial components and
unravel a previously unrecognized functional hetero-
geneity among this important population of innate
lymphoid cells.
INTRODUCTION
Lymphoid tissue inducer cells (LTi) are required for embryonic
development of secondary lymphoid tissue in the mouse
(Mebius, 2003). Recently, we identified human LTi cells in both
fetal and postnatal tissue. These cells express CD127 (IL-7
receptor a) and the transcription factor RORC, as RORg is called
in humans, and produce IL-17 and IL-22 (Cupedo et al., 2009). In
this same study we also identified a related cell type that shares
characteristics with both LTi and NK cells, in that they express
NK cell-associated markers such as CD56 and NKp44, as well
as RORC and CD127. Cella et al. (2009) independently identified
CD56+ NKp44+RORC+ cells in human tonsils, intestinal lamina752 Immunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc.propria, and Peyer’s patches. These cells produced IL-22 and
have been named NK-22 cells. More recent analysis revealed
that the CD56+CD127+RORC+ cells we described are identical
to NK-22 cells and are developmentally related to LTi-like cells
(Crellin et al., 2010). Concurrent to these observations, a popula-
tion of RORC+ and NKp46+ cells was detected in the human
colon (Luci et al., 2009). An analogous population of noncyto-
toxic IL-22-producing cells expressing both RORgt and NKp46
was also present in mouse gut lamina propria, isolated lymphoid
follicles, and Peyer’s patches (Luci et al., 2009; Sanos et al.,
2009; Satoh-Takayama et al., 2008). These cells mediate an
innate response against enteric bacteria such as Citrobacter
rodentium, which is dependent on IL-22 (Cella et al., 2009;
Satoh-Takayama et al., 2008; Zheng et al., 2008). Interestingly,
it was recently demonstrated that a population of innate
lymphoid cells with LTi-like characteristics mediate pathology
in IL-23-driven colitis models in RAG-deficient mice, suggesting
that these cells may play an important role in certain inflamma-
tory diseases (Buonocore et al., 2010).
It has now been established, in human and mouse, that the
non-T, non-B CD127+RORC+ populations that include the LTi
cells, as well as the NK receptor+ LTi-like cells, are distinct from
conventional NK cells (Crellin et al., 2010; Satoh-Takayama
et al., 2010). However, given the similarities among LTi cells,
NK receptor+RORC+CD127+ cells and cNK cells, as well as their
developmental dependency on the transcriptional repressor Id2,
these cells may all originate from a common precursor and may
be considered members of a family of cells that we call here
innate lymphoid cells (ILC). Innate cells that may belong to the
same ILC family were found in lymphoid clusters interspersed
in adipose tissue, and were, like LTi cells and cNK, dependent
on the Id2 and the gamma common receptor (Moro et al.,
2010). The phenotype of these ‘‘natural helper’’ cells is similar
to that of LTi cells, but they develop independently of RORgt.
Natural helper cells produce the Th2 cytokines IL-4, IL-5, and
IL-13, but not IL-17 or IL-22 (Moro et al., 2010). Another group
described a very similar cell type, present in the spleen and lymph
nodes of mice, that responded to the Th2-inducing cytokines
IL-25 and IL-33, and were named nuocytes (Neill et al., 2010).
The developmental requirements for LTi cells have been
explored at the genetic level (Boos et al., 2007; Eberl et al.,
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for LTi cell activation have not been fully characterized. IL-7 can
activate LTi cells, leading to an increased number of LTi cells and
the development of ectopic lymph nodes and cecal patches in
IL-7 transgenic mice (Meier et al., 2007), but it is unclear whether
IL-7 acts alone or in concert with other factors. IL-15 activates
human NK-22 cells from the tonsil (Cella et al., 2009), but it has
yet to be determined what contribution IL-15 and also IL-2 may
make to LTi cell activation. LTi and LTi-like ILC may also be
activated by IL-23, which has been reported to induce IL-22
production by human NK-22 cells (Cella et al., 2009), and mouse
LTi cells strongly express IL-23R and produce IL-17 in response
to stimulation (Takatori et al., 2009).
CD127+ LTi-like ILC may also be influenced by the presence
of bacteria and bacterial products. The development of
NKp46+Rorgt+ cells in the gut is modified by the presence of
commensal bacteria (Sanos et al., 2009; Satoh-Takayama
et al., 2008). LTi-induced development of isolated lymphoid
follicles in the gut also required colonization with commensal
bacteria (Tsuji et al., 2008). Further, mouse LTi cells produced
IL-17 and IL-22 in response to in vivo challenge with the
yeast cell wall component zymosan (Takatori et al., 2009) or
stimulation with TLR5 ligand flagellin (Van Maele et al., 2010).
However, Takatori et al. (2009) did not address the issue of
whether LTi cell activation was direct or was mediated via
antigen presenting cells (APCs), and Van Maele et al. (2010)
found that dendritic cells were required. Moreover, Cella et al.
(2009) have suggested that human NK-22 cells cannot respond
directly to TLR stimulation.
Here we have examined the cytokine production profile of
human LTi cells and the physiological signals that promote
secretion of cytokines by these cells. We show that human LTi
and CD56+ LTi-like cells produce large amounts of IL-2, as well
as the Th2 cytokines IL-5 and IL-13. Given that LTi cells and
NK receptor+RORC+CD127+ ILC are important players in the
mucosal immune system, we have addressed the question of
whether human CD127+ LTi-like ILC cells are capable of directly
sensing and responding to Toll-like receptor (TLR) ligands. We
show here that TLR2 is capable of inducing not only IL-22 but
also IL-13 and IL-5 secretion from human LTi-like ILC.
RESULTS
CD56+CD127+ and CD127+ LTi-like Cells Produce IL-13,
IL-5, and IL-2
We, and others, have recently observed that human LTi and
CD56+ LTi-like cells produce IL-22 (Cella et al., 2009; Cupedo
et al., 2009; Hughes et al., 2009) as well as IL-17 and tumor
necrosis factor (TNF). Here we expanded our characterization
of the cytokines produced by human LTi-like cells, giving
particular attention to those cytokines that might play a role in
mucosal immunity and homeostasis. We isolated CD117
(cKit)+CD56+CD127+ cells, CD117+CD127+ LTi-like cells, and
CD127CD56+ cNK cells from lineage (CD3, TCRab, TCRgd,
CD19, CD14, and CD34)-negative tonsil cells (Figure S1A avail-
able online) The purified LTi-like cells from human tonsil
expressed RORC transcripts as previously described (Cupedo
et al., 2009), and flow cytometry analysis showed that they
also expressed RORC protein. The histogram shows one peakIthat is shifted compared to the isotype control, suggesting that
all cells are RORC positive, but we cannot exclude that there
may be cells within the population that do not express RORC
protein (Figure 1A).
Although LTi-like cells expressed CD117, they were negative
for CD34, indicating that they are distinct from hematopoietic
precursor cells. After stimulation with PMA plus ionomycin,
LTi-like cells produced substantial amounts of IL-13
(Figure 1B) and high amounts of IL-2 (Figure 1C), which are
comparable to IL-2 amounts secreted by naive T cells (data
not shown). IL-4, IL-10, and IL-12 were not produced (data not
shown). To make sure that IL-2, IL-13, and IL-22 are coproduced
by the same cells, we analyzed the production of these cytokines
by intracytoplasmic staining of in vitro-expanded LTi-like cells,
whose cytokine profile is similar to the fresh cells, and observed
coproduction of IL-22 with either IL-13 or IL-2 by CD127+ LTi-like
cells, whereas cNK did not produce these cytokines (Figure 1D
and data not shown).
IL-13 is often associated with IL-5 expression, and recent
studies identified non-T non-B cells innate lymphoid cells that
produce high amounts of IL-13 and IL-5 (Moro et al., 2010; Neill
et al., 2010; Saenz et al., 2010). Although IL-5 was not detectable
in the supernatants of freshly isolated LTi-like cells stimulated
with PMA plus ionomycin ex vivo (data not shown), IL-5 was
expressed by expanded CD127+ LTi cell lines and clones
(Figures 1D and 1E). These clones are representative of
CD127+ LTi-like cells, as indicated by the fact that they ex-
pressed RORC transcripts, were able to produce IL-22, and
showed LTi-like activity in vitro (Crellin et al., 2010).
Recently we reported that there is a clonal heterogeneity in
LTi-like cells because we found clones that produced IL-17
but not IL-22, clones that produced both cytokines, as well as
clones that produced only IL-22 (Crellin et al., 2010). We also
observed clonal heterogeneity with respect to production of
IL-2, IL-5, and IL-13 as compared to IL-22. Although the majority
of clones produced high IL-22 and low IL-5, some clones
(10%–15%) produced low IL-22 and IL-17, but high IL-13,
IL-5, and IL-2 (Figure 1F and data not shown). Further analysis
did not reveal a correlation between IL-13 and IL-22 production;
however, therewas a correlation between IL-13 and IL-2 produc-
tion (r2 = 0.6) (Figure S1B). These IL-22loIL-13hiIL-5hi clones
expressed similar amounts of RORC protein to IL-22hi clones
(Figure S1C). In addition, these clones expressed GATA3,
a transcription factor associated with a Type 2 cytokine
response in T cells; however, the amount of expression of
GATA3 was not different from IL-22hi clones (Figure S1D). The
clones that produced IL-5 and IL-13 did not produce detectable
amounts of IL-4.
Taken together, our results indicate that linCD117+CD127+
ILC produce not only IL-22 but also the Th2 cytokines IL-5
and IL-13. The isolation of cloned lines of CD127+ ILC that
produce IL-13 but not IL-22, and clones that express IL-22
but not IL-13, might suggest that CD127+ ILC can undergo
polarization.
Stimulation with IL-2 and IL-15 Induces Cytokine
Production by LTi and CD56+LTi-like Cells
To determine which physiological stimuli might stimulate LTi-like
cells, we tested the effects of IL-2, IL-7, and IL-15 onmmunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc. 753
Figure 1. CD56+CD127+ and CD127+ LTi-like Cells Produce IL-13, IL-5, and IL-2
(A) RORC protein expression in CD127+ LTi cells from tonsil, as determined by flow cytometry.
(B and C) Flow cytometry sorted cells were stimulated ex vivo with PMA and ionomycin for 24 hr, and IL-13 (B) and IL-2 (C) secretion was determined by Luminex.
(D) CD127+ LTi-like cells were expanded in vitro, and intracellular cytokine staining was performed after stimulation with PMA plus ionomycin for 6 hr, in the pres-
ence of brefeldin A.
(E and F) Single cell clones of CD117+CD127+ LTi-like cells were generated, and intracellular cytokine staining was performed as in (D).
Data shown are as follows. (A and D) A single donor representative of at least three donors. (B) and (C) represent the mean and SEM of at least three donors. (E)
Each dot represents a separate clone expanded from a single donor, with mean and SEM indicated by horizontal lines. (F) Two representative clones are shown
from one donor. See Figure S1 for additional data.
Immunity
Cytokine Secretion by Human LTi-like CellsCD56+CD127+ and CD127+ LTi-like cells because the receptors
of these three cytokines are expressed on both populations. We
observed that both CD56+CD127+ and CD127+ LTi-like cells
proliferated in response to all three cytokines, although the754 Immunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc.response to IL-2 and IL-15 was more robust than that to IL-7
(Figure 2A). As previously reported for NK-22 cells (Cella et al.,
2009), the CD56+CD127+ cells and the CD56CD127+ produced
IL-22 ex vivo after stimulation with IL-15. CD56CD127+ and
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Figure 2. Stimulation with IL-2, IL-15, and IL-23 Induces Cytokine Production by LTi and CD56+ LTi-like Cells
(A) Proliferation and cytokine secretion by flow cytometry sorted tonsil cells, either unstimulated or stimulated with IL-2 (1000 U/ml), IL-7 (10 ng/ml), or IL-15
(10 ng/ml) for 6 days.
(B) IL-22 secretion by sorted cells as in (A) stimulated with 10, 100, or 1000 U/ml of IL-2.
(C) IL-22 mRNA expression in cultured CD127+ LTi cells stimulated for 18 hr with the indicated doses of IL-2. IL-22 mRNA was analyzed by quantitative RT-PCR.
Samples were normalized via 18S expression and expressed as arbitrary units.
(D) IL-22 secretion and proliferation by flow cytometry sorted cells stimulated with IL-2 (10 U/ml), IL-23 (50 ng/ml), or IL-2+IL-23 for 6 days.
The mean and SEM of at least three donors is shown for (A)–(D). See Figure S2 for additional data.
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Cytokine Secretion by Human LTi-like CellsCD56+CD127+ cells also produced IL-22 after stimulation with
IL-2 in a dose-dependent manner (Figures 2B and 2C), whereas
IL-7 induced only low or undetectable amounts of IL-22.
CD56+CD127 cNK cells responded to IL-2 and IL-15 by
producing IFN-g but not IL-22, as expected, but showed no
response to IL-7 (Figure 2A). Overall, these data suggest that
stimulation with gc cytokines alone is sufficient to induce
the activation of LTi-like cells, resulting in proliferation and the
production of IL-22.
Human CD127+ LTi-like Cells Require Costimulation
to Respond to IL-23
It has been reported that NKp44+ CD56+RORC+ cells from
the tonsil directly respond to IL-23 (Cella et al., 2009). We
observed, however, that IL-23 stimulated IL-22 production of
CD56+CD127+ and CD127+ LTi-like cells only in the presence
of another stimulus. Coculture with IL-23 and low concentrationsIof IL-2 (10 U/ml), which by itself did not induce production of
cytokines (Figure 2B), induced high amounts of IL-22 secretion
from CD127+ LTi-like cells, and to a lesser extent from
CD56+CD127+ cells (Figure 2D), but not from cNK cells. IL-23
alone did not provide a proliferative signal to either CD127+
LTi-like cells or CD56+CD127+ cells, and the addition of IL-23
to IL-2 did not induce a greater degree of proliferation as
compared to IL-2 alone (Figure 2D). The IL-22 produced by
IL-2- and IL-23-activated LTi cells has biological activity
because we observed IL-10 production by the epithelial cell
line Colo-205 cells after incubation with supernatants from stim-
ulated CD56+CD127+ or CD127+ LTi-like cells. IL-10 production
correlated with the amount of IL-22 in the supernatant
(Figure S2). Our findings that IL-22 produced by LTi cells induces
IL-10 production by Colo-205 cells are in line with findings of
others (Cella et al., 2009; Nagalakshmi et al., 2004). Together
our data indicate that in our system, CD56+CD127+ andmmunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc. 755
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Cytokine Secretion by Human LTi-like CellsCD127+ LTi-like cells require costimulation in order to respond to
IL-23.
Human CD56+CD127+ and CD127+ LTi-like Cells
Express TLRs
Cella et al. (2009) reported that bacterial products induce IL-23
production inmyeloid cells,which in turn stimulates IL-22produc-
tion by enriched NKp44+CD56+RORC+ cells. Here, we consid-
ered the hypothesis that TLR agonists may also directly act on
RORC+NKp46+cells.ByusingquantitativeRT-PCR,weobserved
broadexpressionofmanyTLR transcripts, includingTLR1, 2, 5, 6,
7, and 9 on ex vivo CD56+CD127+ and CD127+ LTi-like cells and
cNK cells. (Figure 3 and Figure S3A). TLR3 and TLR4were not ex-
pressed at substantial amounts on these cell types.
CD56+CD127+ and CD127+ LTi-like cells expressed TLR2, and
the degree of expression was highest on CD56+CD127+ cells,
although still lower than on CD14+ monocytes (Figure 3A). The
coreceptors for TLR2, TLR1, or TLR6 were also expressed at
substantial amounts, raising the possibility that TLR2 is functional
onCD56+CD127+ andCD127+ LTi-like cells. The TLR2 signal was
not due to contamination because TLR2 was also detected on
cloned lines of CD127+ LTi-like cells, and indeed correlated with
RORC expression (Figure 3B). Additionally, freshly isolated
CD127+ LTi-like cells were positive for TLR2 protein as deter-
mined by flow cytometry, as were expanded CD127+ LTi-like
cell lines and clones (Figure 3C). These data indicate that human
LTi-like ILCexpress a broad rangeof TLRs including TLR1, 2, 5, 6,
7, and 9, which suggests that these cells can directly respond to
microorganisms.
Human LTi-like Cells Produce IL-22 and Proliferate
in Response to TLR2 Costimulation
Initial experiments conducted with TLR ligands alone did not
reveal any effect on CD56+CD127+ or CD127+ LTi-like cell prolif-
eration or cytokine secretion (data not shown), in agreement with
what was previously reported (Cella et al., 2009). However, in
nonmyeloid cells such as T cells and cNK cells, TLR signals are
often costimulatory, in that they require additional stimulation
through either TCR or cytokine receptors (Crellin et al., 2005;
Girart et al., 2007; Komai-Koma et al., 2004; Liu et al., 2006;
Sawaki et al., 2007; Sutmuller et al., 2006). Therefore, we cocul-
tured CD56+CD127+ cells, CD56CD127+ cells, and cNK cells
ex vivo with the TLR1 and 2 ligand Pam3Cys (Pam3) in the
presence or absence of a low dose of IL-2 (10 U/ml) or IL-15
(1 ng/ml) and observed that Pam3 induced IL-22 production
from CD127+ LTi-like cells, and to a greater extent
CD56+CD127+ cells, in the presence of IL-2 (Figure 4A) or IL-15
(Figures S4A and S4B). A similar effect was observed with the
TLR2 and 6 agonist Pam2Cys in the presence of IL-2 (data not
shown), whereas TLR5, 7, or 9 agonists had no effect on IL-22
production (Figure S4C and data not shown). cNK cells did not
produce IL-22 after costimulation with Pam3Cys and IL-2
(Figure 4A). Neither CD56+CD127+ nor CD127+ LTi-like cells
produced IFN-g in response to this stimulus, nor was production
of IL-17 or TNF increased (data not shown). Costimulation with
low concentrations of IL-2 and Pam3 resulted in a 2- to 3-fold
increase in cell numbers for both CD56CD127+ cells and
CD56+CD127+ cells, as compared to IL-2 alone (Figure 4B),
whereas Pam3 alone did not induce proliferation. Although the756 Immunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc.ex vivo culture was relatively lengthy (6 days), we have previously
observed that the phenotype of LTi-like cells is very stable in
culture (Crellin et al., 2010), andwehave never observed differen-
tiation of LTi cells in vitro within this period of time. Taken
together, these data suggest that in the appropriate cytokine
environment, CD127+ LTi cells can increase in numbers and
secrete cytokines in response to bacterial products. We
confirmed that expanded CD127+ LTi-like cells produced IL-22
protein, by intracellular staining performed after an overnight
stimulationwith IL-2 plus Pam3 (Figure 4C). Additionally, stimula-
tion of expanded CD127+ LTi-like cells overnight with IL-2 plus
Pam3 increased IL-22 message (Figure 4D) and secreted IL-22
(Figure S4D) above that observed with IL-2 alone. The observa-
tion that Pam3 plus IL-2 induces IL-22 production from in vitro
expanded CD56+CD127+ and CD127+ LTi-like cells, which
were rigorously assessed for lack of myeloid cells, excludes the
possibility that an undetectable contamination with APCs, or
other cytokine-secreting cell types, was contributing to the
TLR2 response observed with freshly isolated cells. Further, the
overnight stimulation resulting in intracellular cytokineproduction
and increased IL-22 message confirms that the stimulation in
cytokine production observed with ex vivo cells is not a result
of the increased proliferation also observed in these cultures.
Neither IL-23 nor Pam3 could stimulate tonsillar LTi-like cells
alone; however, when used in combination, a small increase in
IL-22 production from CD127+ LTi-like cells was observed
(Figure 4E). In contrast, IL-23 and Pam3 strongly increased
IL-22 production by CD56+CD127+ cells of some but not of
all donors (Figure 4E). The reasons for this large donor-to-donor
variability are unclear but may be attributed to the various
states of inflammation of the tonsils used to isolate the
CD56+CD127+ cells.
Although human LTi-like cells express TLR2 and respond to
TLR2 activation, mouse LTi andNKp46+Rorgt+ cells lack expres-
sion of TLR2 transcripts and protein (Figures S5A and S5B), and
purified mouse LTi and intestinal NKp46+ cells do not respond to
TLR2 stimulation (Figure S5C and data not shown). However,
treatment of total splenocytes (containing APCs) from Rag2/
mice with IL-2 plus Pam3 did induce an increase in IL-22 produc-
tion from LTi cells, most probably in an indirect manner
(Figure S5D). Further, no alteration in numbers of intestinal
NKp46+Rorgt+ cells was observed in Tlr2/ mice (data not
shown).
Taken together, these data indicate that TLR agonists, in
particular TLR2 agonists, directly act on human LTi-like ILC,
thus regulating cytokine production by these cells in conjunction
with IL-2 and/or IL-23.
IL-13 and IL-5 Are Induced by TLR2 Costimulation
with IL-2, but Not with IL-23
Having established that a strong nonphysiological activation was
able to induce IL-13 production from CD127+ LTi-like cells, we
explored physiological signals serving as triggers for IL-13 and
IL-5 production. Stimulation of ex vivo (data not shown) and
expanded CD127+ cells with IL-2 induced IL-13 message
(Figure 5A), similar to what we observed with IL-22 (Figure 2C).
We also examined IL-13 expression in ex vivo CD56+CD127+,
CD127+ LTi-like cells, and cNK cells, costimulated with Pam3.
Substantial amounts of IL-13 were produced in response to
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Figure 3. Human CD56+CD127+ and CD127+ LTi-like Cells Express TLRs
(A) The indicated populations were sorted with flow cytometry, and quantitative RT-PCR for TLR1, 2, and 6 mRNAs was performed. Samples were normalized
with GAPDH expression levels and expressed as arbitrary units.
(B) Single cell clones of CD127+ LTi-like cells were expanded ex vivo, and quantitative RT-PCR for TLR2 and RORC mRNAs was performed. Samples were
normalized via 18S expression and expressed as arbitrary units. Left panel of (B) shows TLR2 mRNA levels in individual CD127+ LTi-like cell clones from two
independent donors, compared to the levels in bulk LTi-like or cNK cultures, while in the right panel the relationship between TLR2 and RORC mRNA levels
in individual LTi-like cell clones from a single donor is shown.
(C) TLR2 protein expression on human tonsil cells, expanded CD127+ LTi cell lines, and clones, as determined by flow cytometry.
The mean and SEM of three donors is shown in (A), each dot represents a single clone in (B), with mean and SEM indicated by horizontal lines, and one donor
representative of at least three is shown in (C). See Figure S3 for additional data.
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Cytokine Secretion by Human LTi-like Cellsstimulation with IL-2 plus Pam3 (Figure 5B) or IL-15 plus Pam3
(data not shown). Although ionomycin and PMA did not induce
IL-5 by freshly isolated CD127+ cells, stimulation with IL-2 plus
Pam3 did induce IL-5 (Figure 5B), indicating that ex vivoICD127+ LTi-like cells have the capacity to produce IL-5 under
the appropriate stimulation.
Strikingly, IL-23 and IL-2 costimulation did not induce IL-13 or
IL-5 production from either CD56+CD127+ or CD127+ LTi-likemmunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc. 757
Figure 4. Human LTi-like Cells Produce IL-22 and Proliferate in Response to TLR2 Costimulation
(A) Cytokine secretion of flow cytometry sorted cells stimulated with IL-2 (10 U/ml), TLR2 agonist Pam3Cys (1 mg/ml), or IL-2+Pam3, for 6 days, as determined by
ELISA.
(B) Proliferation of cells stimulated in (A).
(C) CD127+ LTi-like cells were expanded in vitro and then stimulated for 24 hr as indicated, in the presence of Brefeldin A for the final 6 hr. Intracellular cytokine
production was analyzed by flow cytometry.
(D) CD127+ LTi-like cells were expanded in vitro and then stimulated for 18 hr as indicated, prior to qRT-PCR analysis of IL-22 mRNA levels.
(E) Cytokine secretion of flow cytometry sorted cells stimulated with IL-23 (50 ng/ml), Pam3, or IL-23 + Pam3 for 6 days, as determined by ELISA.
For (A) and (E) each dot represents a single donor, with the mean and SEM indicated by horizontal lines, while the mean and SEM of three donors is shown in (B).
(C) and (D) represent a single donor of at least three. See Figures S4 and S5 for additional data.
Immunity
Cytokine Secretion by Human LTi-like Cellscells (Figure 5B), even though IL-23 plus IL-2 induced substantial
amounts of IL-22. Similarly, coculture with IL-23 plus Pam3 did
not induce IL-13 or IL-5 production (Figure 5B). Expanded
CD127+ LTi-like cells stimulated with Pam3 and IL-2 increased
IL-13 message above that induced by IL-2 alone (Figure 5C), in
agreement with cytokine production of the freshly isolated cells.
Additionally, overnight stimulation with Pam3 plus IL-2 induced
IL-13 and IL-22 production in expanded CD127+ LTi-like cells
(Figure 5D). IL-23, however, did not upregulate nor inhibit IL-13
message (Figure 5C). CD127+ LTi cell clones also displayed758 Immunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc.increased IL-13 production after stimulation with IL-2 plus
Pam3, although expression varied between clones (Figure S6).
Taken together our data indicate that the composition of the
cytokine milieu determines IL-5 and IL-13 production by
CD56+CD127+ and CD127+ LTi-like cells.
NF-kB Activation Contributes to TLR2-Costimulated
IL-13 and IL-22 Production
As demonstrated above, IL-2 with IL-23 stimulation induced
IL-22 but was unable to induce IL-13 production (Figure 5).
Figure 5. IL-13 and IL-5 Are Induced by TLR2 Costimulation with IL-2, but Not with IL-23
(A) CD127+ LTi-like cells were expanded in vitro and stimulated for 18 hr with IL-2 as indicated. IL-13 mRNA levels were analyzed by quantitative RT-PCR.
(B) Cytokine secretion by flow cytometry sorted cNK, CD127+CD56+, and CD127+ LTi-like cells, stimulated with IL-2 (10 U/ml), Pam3Cys (1 mg/ml), and IL-23
(50 ng/ml), for 6 days, as determined by ELISA and Luminex.
(C) CD127+ LTi-like cells were expanded in vitro, then stimulated for 18 hr as indicated, and IL-13 mRNA levels were analyzed by quantitative RT-PCR.
(D) CD127+ LTi-like cells were expanded in vitro and were stimulated for 24 hr as indicated, in the presence of Brefeldin A for the final 6 hr. Intracellular cytokine
production of IL-22 and IL-13 was analyzed by flow cytometry.
For (A) and (B), the mean and SEM of at least three donors are shown. (C) and (D) represent a single donor of at least three. See Figure S6 for additional data.
Immunity
Cytokine Secretion by Human LTi-like CellsIn contrast, stimulation with TLR2 ligand Pam3Cys, in combina-
tion with either IL-2 or IL-15, induced IL-22 and IL-13, as well as
IL-5, suggesting that the signaling requirements for production of
these cytokines are different. Because TLR ligation is a well-
known activator of NF-kB (Kaisho and Akira, 2006), we expected
that inhibition of NF-kB would compromise costimulation with
Pam3. Indeed, NF-kB inhibition with Bay 11-7082 blocked
Pam3 plus IL-2-induced IL-22 and IL-13mRNA in a dose-depen-
dent manner (Figure 6A). In contrast, inhibiting NF-kB had only
a modest, possibly nonspecific, effect on IL-2 plus IL-23-
induced IL-22 production (Figure 6B). A pan-Jak inhibitor
blocked all responses to IL-2 plus Pam3 or IL-2 plus IL-23 cos-
timulation (Figures 6A and 6B), whereas inhibition of ERKIsignaling by a MEK inhibitor had no effect (data not shown).
These data indicate that TLR2 responsiveness is NF-kB depen-
dent and requires a Jak-dependent costimulatory signal, such as
that provided by gamma common cytokines.
Autocrine IL-2 Contributes to TLR2-Induced IL-22
Production
As described above, we observed substantial amounts of IL-2
production from CD56+CD127+ and CD127+ LTi-like cells
stimulated with PMA plus ionomycin. Additionally, IL-2 mRNA
transcripts were present in ex vivo CD56+CD127+ and CD127+
LTi-like ILC and were 10-fold higher than cNK, suggesting
in situ IL-2 production (data not shown). Given that CD127+mmunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc. 759
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Figure 6. NF-kB Activation Contributes to TLR2 Costimulated IL-13
and IL-22 Production
CD127+ LTi-like cells were expanded in vitro and stimulated with IL-2
(10 ng/ml), Pam3Cys (1 mg/ml), or IL-23 in the presence or absence of inhibitors
to NF-kB or JAK kinase, as indicated, for 18 hr. Inhibitor concentrations are
indicated in mM. IL-22 or IL-13 mRNA levels were analyzed by quantitative
RT-PCR and normalized to 18S. For (A) the level of IL-22 or IL-13 mRNA
produced by the cells stimulated with IL-2+Pam3 was set at 100% as refer-
ence, while for (B) the IL-2+IL-23 stimulation served as the control. Vehicle
was included in control conditions lacking inhibitors. Mean and SEM of at least
three donors are shown.
Immunity
Cytokine Secretion by Human LTi-like CellsLTi-like cells responded to low amounts of IL-2 costimulation, we
examined whether autocrine IL-2 is involved in the response to
TLR2 costimulation. We observed a 2-fold increase in IL-2
mRNA expression in ex vivo or expanded CD56+CD127+ and
CD127+ LTi-like cells when stimulated with IL-15 and Pam3, as760 Immunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc.compared to IL-15 alone (Figure 7A). However, only low amounts
of IL-2 protein were detected under these conditions. Nonethe-
less, these low amounts of IL-2 were biologically active, as
indicated by the fact that the addition of a neutralizing IL-2
antibody to CD56+CD127+ or CD127+ LTi-like cells stimulated
with IL-15 and Pam3 reduced IL-22 secretion by65%,whereas
isotype controls had no effect (Figure 7B). The increased prolif-
eration induced by TLR2 costimulation was reduced by 25%
by the addition of an IL-2 blocking antibody (Figure 7C).
The large discrepancy of the amounts of IL-2 produced by LTi
cells after activation with PMA plus ionomycin and IL-15 plus
Pam3 may be caused by autocrine consumption of IL-2 under
these latter conditions. Indeed, we have observed that ex vivo
CD56+CD127+ and CD127+ LTi-like cells express IL-2Ra
(CD25) (Crellin et al., 2010). In light of the autocrine IL-2 produc-
tion, we questioned whether CD25 expression is influenced by
TLR2 stimulation. After culture with either low amounts of IL-2
plus Pam3 (Figure 7D) or IL-15 plus Pam3 (data not shown),
we observed that CD25 expression was increased on
CD56+C127+ and CD127+ LTi-like cells, as compared to IL-2
alone. Expression of other activation markers, such as CD69,
was not altered, suggesting a specific effect on CD25 expres-
sion. Interestingly, the upregulation of CD56 on CD127+ LTi-like
cells normally observed after IL-2 stimulation was greatly
decreased in the presence of TLR2 costimulation (Figure S7).
CD56 expression on CD56+CD127+ cells was unaffected, indi-
cating that the effect of TLR2 was restricted to the maturation
phenotype of CD127+ LTi-like cells. Expression of NKp46 was
unchanged, suggesting a specific effect on CD56 expression
(data not shown).
Taken together, these data show that IL-2 produced by
LTi-like ILC upon activation can amplify an ongoing signal
induced by TLR2 signaling in an autocrine manner.
DISCUSSION
LTi and NK receptor-positive LTi-like innate lymphoid cells (ILC)
are emerging as new players in the innate immune response
(Vivier et al., 2009; Spits and Di Santo, 2010). Both in humans
and mouse these ILC have been shown to produce IL-17 (Cu-
pedo et al., 2009; Takatori et al., 2009; Van Maele et al., 2010)
and IL-22 (Cella et al., 2009; Cupedo et al., 2009; Hughes
et al., 2009; Luci et al., 2009; Sanos et al., 2009; Satoh-Ta-
kayama et al., 2008). Given the importance of CD127+RORC+
ILC in the innate immune response (Cella et al., 2009; Satoh-Ta-
kayama et al., 2008; Zenewicz et al., 2008), it is important to
determine the cytokine production profile of these cells. We
found that in addition to LTa and b, TNF, IL-17, and IL-22,
CD127+RORC+ LTi-like ILC also secrete IL-2, IL-5, and IL-13.
Importantly, the production of cytokines that act on cells of the
adaptive immune system, such as IL-2, may suggest that
CD127+RORC+ cells are involved in regulating the adaptive
immune system as well.
The identification of a non-T cell-derived source of IL-2, IL-13,
and IL-22 is of significance, particularly in the context of the gut.
T regulatory cells are abundant in the gut and require IL-2 for
optimal expansion, and IL-2 drives the development of
‘‘induced’’ T regulatory cells (Curotto de Lafaille and Lafaille,
2009; Josefowicz and Rudensky, 2009). Because autocrine
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Figure 7. Autocrine IL-2 Contributes to TLR2-Induced IL-22 Production
(A) Ex vivo (top) or in vitro expanded (bottom) cNK and CD127+ LTi-like cells were stimulated with IL-15 (1 ng/ml) or IL-15+Pam3 (1 mg/ml) overnight, and quan-
titative RT-PCR for IL-2 mRNA was performed. Samples were normalized with 18S expression and expressed as arbitrary units.
(B) Cytokine secretion by freshly isolated sorted cells stimulated with IL-15 (1 ng/ml) + Pam3 (1 mg/ml) in the presence or absence of a neutralizing IL-2 antibody
(10 mg/ml) for 6 days, as determined by ELISA.
(C) Proliferation of cells stimulated as in (B).
(D) Expression of CD25 and CD69 on flow cytometry sorted cells after 6 day stimulation with IL-2 (10 U/ml) + Pam3 (1 mg/ml).
A single experiment representative of at least two donors is shown in (A) and (D), while themean and SEM of three donors is shown in (B) and (C). See Figure S7 for
additional data.
Immunity
Cytokine Secretion by Human LTi-like CellsIL-2 production contributes to the cytokine response of
CD127+RORC+ cells induced by TLR2 costimulation, defi-
ciencies in IL-2 produced by LTi and CD56+ LTi-like cells may
result in pathology in the gut. IL-22 and IL-13 are required for
normal wound healing in the mouse gut (Pickert et al., 2009;
Seno et al., 2009), thus further supporting the idea that LTi-like
ILC cells are involved in regulation of the integrity of the epithelial
cell layer in the mouse gut. This may also be the case in human
gut, because IL-22 has been shown to promote the migration
and in vitro ‘‘wound healing’’ of human gut-derived epithelialIcell lines (Brand et al., 2006). By using a punch biopsy model,
Seno et al. (2009) demonstrated that IL-13 and IL-4 were upregu-
lated in the wound bed and that blocking IL-4 and IL-13 delayed
wound healing.Whereas IL-4 and IL-13may be produced by Th2
cells present in the wound bed, an involvement of IL-13-
producing ILC cannot be excluded.
CD127+ innate cell types that are dedicated to the production
of the Th2 cytokines IL-4, -5, and -13 have been recently discov-
ered in the mouse. These cells, which were called natural helper
lymphocytes in one study (Moro et al., 2010) and nuocytes inmmunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc. 761
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Cytokine Secretion by Human LTi-like Cellsanother study (Neill et al., 2010), are RORgt negative (Moro et al.,
2010), may be related to RORgt+CD127+ LTi cells because both
LTi-like ILC and natural helper lymphocytes express CD127 and
cKit, and depend on expression of Id2 (Moro et al., 2010). Our
clonal analysis suggests the existence of subpopulations of
human LTi-like ILC that may have different functions. In addition
to IL-17- or IL-22-specific LTi clones (Crellin et al., 2010), we
identified clones that produce IL-5 and IL-13 but no IL-22 or
IL-17. These IL-5- and IL-13-producing CD127+ cells may not
represent the human equivalents of natural helper lymphocytes
or nuocytes, because in contrast to the mouse cells (Moro
et al., 2010; Neill et al., 2010), human CD127+ cells express
RORC transcripts and protein and fail to produce IL-4. However,
we cannot formally exclude that the IL-13+IL-5+IL-22 clones
were derived from cells that were initially RORCneg and that the
culture conditions used to expand these cells induced RORC.
The relative amounts of IL-5 and IL-13 produced by
RORC+CD127+ LTi-like ILC as compared to human nuocytes
and natural lymphocytes is as yet unclear and should await
further identification and characterization of the human equiva-
lents of these cells. The existence in humans of CD127+RORC+
cells with different cytokine production profiles suggests that
one mechanism regulating ILC cytokine production is the
polarization into different subpopulations, much as is the case
with T cells.
Given that CD127+RORC+ cells are most probably functioning
at mucosal interfaces, the possible role of TLRs in regulating
cytokine production in these cells seems logical. Indeed,
CD56+CD127+ and CD127+ LTi-like ILC express a variety of
TLRs including TLR1, 2, and 6; however, only TLR2 agonists,
in the presence of cytokines like IL-2, IL-15, and IL-23, consis-
tently increased cytokine production by CD127+RORC+ cells.
Costimulation of CD127+RORC+ cells with cytokines and Pam3
was blocked both by NF-kB and Jak inhibitors, confirming that
these pathways collaborate inducing cytokine production by
these cells. The fact that TLR2 acts as a costimulus, rather
than as a trigger on its own, as is the case when TLR agonists
stimulatemyeloid cells, is not without precedent. TLR2 promotes
expansion of Treg cells in conjunction with TCR stimulation
(Komai-Koma et al., 2004; Liu et al., 2006; Sutmuller et al.,
2006), and TLR2 stimulation enables CD8+ T cells to respond
to a suboptimal TCR signal, effectively lowering the threshold
for activation (Mercier et al., 2009). Interestingly, TLR2 induced
different responses depending on the cytokine milieu. For
instance, TLR2 engagement induced only IL-5 and IL-13 in the
presence of exogenous IL-2 or IL-15, but not of IL-23. Because
IL-2 stimulates Jak3, and IL-23 stimulates Tyk2, it appears that
IL-5 and IL-13 can be induced by costimulation of the NF-kB
pathway with Jak3, but not by NF-kB and Tyk2 activation. In
contrast, IL-22 can be induced by either combination of signaling
pathways.
It has been reported that polymorphisms of TLR2 are linked
with the disease phenotype in IBD, suggesting that inappropriate
signaling through this receptor, perhaps affecting LTi or LTi-like
cells, may contribute to the pathology (Henckaerts et al., 2007;
Pierik et al., 2006). Increased numbers of linCD117+CD127+
cells, which are most probably identical to the CD127+RORC+
cells described here, are present in the gut of patients with
Crohn’s disease (Chinen et al., 2007). It is possible that762 Immunity 33, 752–764, November 24, 2010 ª2010 Elsevier Inc.CD127+RORC+ cells play a role in the disease process, which
would be consistent with the documented involvement of mouse
LTi-like ILC in bacteria-driven induced innate colitis in RAG-defi-
cient animals (Buonocore et al., 2010). It will be of interest to
investigate the cytokine production profile of LTi cells in inflamed
tissues in Crohn’s disease and the effects of TLR2 agonists on
the activities of these cells.
Overall, it appears that LTi-like ILC produce a broad range of
cytokines and that environmental cues may skew their activation
and differentiation. This has implications both for our under-
standing of normal mucosal homeostasis and for directing future
investigations into disease pathology.
EXPERIMENTAL PROCEDURES
Cell Purification and Sorting
Human tonsils were digested for 30 min in 0.5 mg/ml collagenase IV (Invitro-
gen) at 37C and processed to form a single cell suspension. CD3+ and
CD19+ cells were then depleted via StemCell Technologies, Inc. (Vancouver,
BC) kits. For flow cytometry sorting, cells were labeled with PE-conjugated
anti-CD127 (BD Bioscience, San Jose, CA), PECy7-conjugated anti-CD56
(BD Bioscience), APC-conjugated anti-CD117 (eBioscience, San Diego, CA),
Pacific blue-conjugated anti-CD19 (eBioscience), and FITC-conjugated
anti-CD3, TCR-ab, TCR-gd, and CD14 (eBioscience, San Diego, CA) anti-
bodies. Cells were sorted on a FACSAria (Becton Dickinson) to more than
95% purity. Cells were sorted as lineage (CD3CD19TCR-abTCR-
gdCD14CD34) CD117+CD127+CD56+ or lineage CD117+CD127+CD56.
Tonsils were obtained from Bio-options (Fullerton, CA). Human blood use was
approved by the Western Institutional Review Board.
Animal Experiments
RorcGFP/+ BAC transgenic mice (12 weeks old) were used for lamina propria
lymphocyte isolation as described (Satoh-Takayama et al., 2008). Small intes-
tine was isolated and Peyer’s patchs removed. Epithelial cells were eliminated
by incubation with 0.5 mM EDTA. Lamina propria lymphocytes (LPLs) were
isolated with 1 mg/ml collagenase (Sigma Aldrich). LPLs were further purified
with discontinuous Percoll gradients (40% and 75%). For cell sorting, LPLs
were stained with CD3 and NKp46 antibodies. CD3 subsets differing in
NKp46 and RORgt expression were sorted with a FACSAria (Becton Dickin-
son).
To isolate splenic LTi cells, splenocytes from Rag2/ mice (Taconic) were
harvested, and red blood cells were lysed. The splenocytes were then stained
with anti-CD11c, B220, CD3, CD8a (all FITC), CD4-APC or A700, and CD127-
PE (all antibodies from eBioscience). Lin(CD11c, B220)CD4+CD127+ LTi cells
were then sorted by flow cytometry to more than 95% purity. Splenic LTi cells
were cultured in RPMI plus 10% FCS. All animal care and experiments were
performed according to protocols approved by the Institutional Use and
Care of Animals Committee.
Expansion of LTi Cell Lines and Clones
Flow cytometry-sorted cells were stimulated with irradiated 106/ml allogeneic
PBMCs (5000 rad) and 1.105/ml irradiated JY EBV-transformed B cells
(7500 rad), in the presence of 1 mg/mL PHA (Roche) and IL-2 (100 U/ml)
(Chiron, Emeryville, CA). IL-2 was replenished every 3 days. Clones were
plated at 1 cell/well via limiting dilution and expanded with the same protocol.
Cell Culture Assays
Cells were cultured in Yssel’smedium (Gemini Bio-Products, Sacramento, CA,
or in-house prepared) plus 1% human AB serum (Gemini Bio-Products).
Freshly isolated cells were plated at 1 3 104 cells/ml, and expanded CD127+
cells were plated at 5 3 104 cells/ml, in 96-well round bottom plates. Where
indicated, cells were stimulated with TLR ligands such as Pam3CYSK4, all
from Invivogen (San Diego, CA). Recombinant human IL-15 and IL-23 used
for stimulation were purchased from R&D systems (Minneapolis, MN). Prolifer-
ation was determined with CellTiterGlo assay (Promega, Madison, WI).
Neutralizing anti-human IL-2 antibody, or isotype control, were purchased
Immunity
Cytokine Secretion by Human LTi-like Cellsfrom BD Biosciences and used at 10 mg/ml. The following inhibitors were used
as indicated in Figure 6: NF-kB inhibitor Bay 11-7082, and JAK inhibitor 1, both
from EMD chemicals/Calbiochem (Gibbstown, NJ, USA).
Quantitative Real-Time PCR
Total RNAwas extracted by using either the RNeasymini ormicro kit (QIAGEN,
Valencia, CA), according to themanufacturer’s instructions. cDNAwas reverse
transcribed with the high-capacity cDNA archive kit (Applied Biosystems,
Foster City, CA). Primers and probes were all predesigned Taqman Gene
Expression Assays from Applied Biosystems. Real-time PCR was performed
on the 7500 Real Time System (Applied Biosystems) machine. All samples
were normalized with either 18S or GAPDH (Figure 2A only) expression level
and expressed in arbitrary units.
For mouse cells, mRNA was extracted from isolated cell subsets with the
RNeasy micro kit (QIAGEN). cDNA was generated with Superscript III
(Invitorogen), and quantitative PCR was performed with the RT2 Profiler PCR
Array System with SYBER Green dye.
Flow Cytometry and Intracellular Cytokine Staining
Cell-surface TLR2 expression was determined with anti-TLR2-PE-Cy7
(eBioscience). Intracellular RORC was detected with anti-RORgt-PE (eBio-
science), according tomanufacturers’ instructions. Intracellular cytokine stain-
ing was performed on ex vivo expanded cell lines stimulated for 6 hr with PMA
(10 ng/mL) and ionomycin (500 nM) (Calbiochem, Gibbstown, NJ), or overnight
with IL-2 (40 U/ml) and Pam3Cys (1 mg/ml), in the presence of 5 mg/ml BFA
(BD Bioscience) for the final 4–6 hr of culture. Cells were stained with LIVE/
DEAD (violet) viability assay (Invitrogen, Carlsbad, CA), and then fixed and per-
meabilized according to manufacturer’s protocol (eBioscience). The following
Abs from BD Biosciences were used: PE-conjugated anti-IL-13 and anti-IL-5
and FITC-conjugated anti-IL-2. AlexaFluor647-conjugated anti-IL-22 (pre-
pared in-house) was also used. Monoclonal mouse anti-human IL-22 anti-
bodies were generated in-house and conjugated with AlexaFluor 647, as
previously described (Trifari et al., 2009). Data were acquired on a LSRII
machine (BD Biosciences) and analyzed with FlowJo software (Tree Star, Ash-
land, OR). During analysis, dead cells were eliminated with the live/dead violet
dye and doublets were eliminated based on light scattering parameters.
Luminex and ELISA
Supernatants were collected, and IL-2, IL-5, IL-13, IL-17A, IFN-g, and TNF-a
were measured by Bioplex bead-based assays (Bio-Rad, Hercules, CA) and
read by Luminex System (Luminex). IL-22 (R&D Systems, Minneapolis, MN)
was measured by ELISA, according to manufacturer’s protocol.
Statistics
Statistical significance was determined by the paired Student’s t test (differ-
ence between two groups or conditions), with 95% confidence intervals. For
analysis of correlation, a linear regression analysis was performed. *p < 0.05,
**p < 0.01.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at doi:10.1016/j.immuni.2010.10.012.
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